Eliminating Risk of Intubation in Very Preterm Infants with Noninvasive Cardiorespiratory Support in the Delivery Room and Neonatal Intensive Care Unit.
Journal
BioMed research international
ISSN: 2314-6141
Titre abrégé: Biomed Res Int
Pays: United States
ID NLM: 101600173
Informations de publication
Date de publication:
2019
2019
Historique:
received:
19
06
2018
revised:
09
11
2018
accepted:
20
12
2018
entrez:
9
2
2019
pubmed:
9
2
2019
medline:
28
5
2019
Statut:
epublish
Résumé
Avoiding intubation and promoting noninvasive modes of ventilator support including continuous positive airway pressure (CPAP) in preterm infants minimizes lung injury and optimizes neonatal outcomes. Discharge home on oxygen is an expensive morbidity in very preterm infants (VPI) with lung disease. In 2007 a standardized bundle was introduced for VPI admitted to the neonatal care unit (NICU) which included delayed cord clamping (DCC) at birth and noninvasive ventilation as first-line cardiorespiratory support in the delivery room (DR), followed by bubble CPAP upon NICU admission. Our goal was to evaluate the risk of (1) intubation and (2) discharge home on oxygen after adopting this standardized DR bundle in VPI born at a regional perinatal center and treated in the NICU over a ten-year period (2008-2017). We compared maternal and neonatal demographics, respiratory care processes and outcomes, as well as neonatal mortality and morbidity in VPI (< 33 weeks gestation) and extremely low birth weight (ELBW, < 1000 g) subgroup for three consecutive epochs: 2008-2010, 2011-2013, and 2014-2017. Of 640 consecutive inborn VPI, 55% were < 1500 g at birth and 23% were ELBW. Constant through all three epochs, DCC occurred in 83% of VPI at birth. There was progressive increase in maternal magnesium during the three epochs and decrease in maternal antibiotics during the last epoch. Over the three epochs, VPI had less risk of DR intubation (23% versus 15% versus 5%), NICU intubation (39% versus 31% versus 18%), and invasive ventilation (37% versus 30% versus 17%), as did ELBW infants. Decrease in postnatal steroid use, antibiotic exposure, and increase in early colostrum exposure occurred over the three epochs both in VPI and in ELBW infants. There was a sustained decrease in surfactant use in the second and third epochs. There was no significant change in mortality or any morbidity in VPI; however, there was a significant decrease in pneumothorax (17% versus 0%) and increase in survival without major morbidity (15% versus 41%) in ELBW infants between 2008-2010 and 2014-2017. Benchmarked risk-adjusted rate for oxygen at discharge in a subgroup of inborn VPI (401-1500 g or 22-31 weeks of gestation) is 2.5% (2013-2017) in our NICU compared with > 8% in all California NICUs and > 10% in all California regional NICUs (2014-2016). Noninvasive strategies in DR and NICU minimize risk of intubation in VPI without adversely affecting other neonatal or respiratory outcomes. Risk-adjusted rates for discharge home on oxygen remained significantly lower for inborn VPI compared with rates at regional NICUs in California. Reducing intubation risk in ELBW infants may confer an advantage for survival without major morbidity. Prenatal magnesium may reduce intubation risk in ELBW infants.
Identifiants
pubmed: 30733962
doi: 10.1155/2019/5984305
pmc: PMC6348842
doi:
Substances chimiques
Oxygen
S88TT14065
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
5984305Références
N Engl J Med. 2008 Feb 14;358(7):700-8
pubmed: 18272893
N Engl J Med. 2010 May 27;362(21):1970-9
pubmed: 20472939
Pediatrics. 2010 Sep;126(3):443-56
pubmed: 20732945
JAMA. 2010 Sep 1;304(9):992-1000
pubmed: 20810377
Cochrane Database Syst Rev. 2010 Dec 08;(12):CD000140
pubmed: 21154343
BMC Pediatr. 2011 Jan 17;11:6
pubmed: 21235822
Early Hum Dev. 2011 Mar;87(3):205-8
pubmed: 21276671
J Clin Invest. 1990 Oct;86(4):1270-7
pubmed: 2212011
Pediatrics. 2013 May;131(5):e1482-90
pubmed: 23610207
Perm J. 2013 Summer;17(3):8-13
pubmed: 24355884
Am J Obstet Gynecol. 2015 Jan;212(1):94.e1-7
pubmed: 25046806
Pediatrics. 2014 Nov;134(5):e1378-86
pubmed: 25332503
PLoS One. 2015 Sep 21;10(9):e0138829
pubmed: 26390401
JAMA. 2016 Aug 9;316(6):611-24
pubmed: 27532916
Cochrane Database Syst Rev. 2016 Aug 22;(8):CD000501
pubmed: 27552058
Acta Paediatr. 2017 May;106(5):755-762
pubmed: 28128874
J Perinatol. 2017 Nov;37(11):1171-1179
pubmed: 28569744
EXCLI J. 2017 Apr 05;16:464-482
pubmed: 28694751
Pediatrics. 2017 Sep;140(3):
pubmed: 28847984
Korean J Pediatr. 2017 Sep;60(9):273-281
pubmed: 29042870
Clin Perinatol. 2018 Jun;45(2):273-291
pubmed: 29747888
Am J Emerg Med. 1994 Mar;12(2):164-6
pubmed: 8161388